Sweeney Colin L, Teng Ruifeng, Wang Hongmei, Merling Randall K, Lee Janet, Choi Uimook, Koontz Sherry, Wright Daniel G, Malech Harry L
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
The Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Stem Cells. 2016 Jun;34(6):1513-26. doi: 10.1002/stem.2332. Epub 2016 Feb 29.
In vitro generation of mature neutrophils from human induced pluripotent stem cells (iPSCs) requires hematopoietic progenitor development followed by myeloid differentiation. The purpose of our studies was to extensively characterize this process, focusing on the critical window of development between hemogenic endothelium, hematopoietic stem/progenitor cells (HSPCs), and myeloid commitment, to identify associated regulators and markers that might enable the stem cell field to improve the efficiency and efficacy of iPSC hematopoiesis. We utilized a four-stage differentiation protocol involving: embryoid body (EB) formation (stage-1); EB culture with hematopoietic cytokines (stage-2); HSPC expansion (stage-3); and neutrophil maturation (stage-4). CD34(+) CD45(-) putative hemogenic endothelial cells were observed in stage-3 cultures, and expressed VEGFR-2/Flk-1/KDR and VE-cadherin endothelial markers, GATA-2, AML1/RUNX1, and SCL/TAL1 transcription factors, and endothelial/HSPC-associated microRNAs miR-24, miR-125a-3p, miR-126/126*, and miR-155. Upon further culture, CD34(+) CD45(-) cells generated CD34(+) CD45(+) HSPCs that produced hematopoietic CFUs. Mid-stage-3 CD34(+) CD45(+) HSPCs exhibited increased expression of GATA-2, AML1/RUNX1, SCL/TAL1, C/EBPα, and PU.1 transcription factors, but exhibited decreased expression of HSPC-associated microRNAs, and failed to engraft in immune-deficient mice. Mid-stage-3 CD34(-) CD45(+) cells maintained PU.1 expression and exhibited increased expression of hematopoiesis-associated miR-142-3p/5p and a trend towards increased miR-223 expression, indicating myeloid commitment. By late Stage-4, increased CD15, CD16b, and C/EBPɛ expression were observed, with 25%-65% of cells exhibiting morphology and functions of mature neutrophils. These studies demonstrate that hematopoiesis and neutrophil differentiation from human iPSCs recapitulates many features of embryonic hematopoiesis and neutrophil production in marrow, but reveals unexpected molecular signatures that may serve as a guide for enhancing iPSC hematopoiesis. Stem Cells 2016;34:1513-1526.
从人诱导多能干细胞(iPSC)体外生成成熟中性粒细胞需要经历造血祖细胞发育,随后进行髓系分化。我们研究的目的是全面表征这一过程,重点关注造血内皮、造血干/祖细胞(HSPC)和髓系定向分化之间的关键发育窗口,以确定相关调节因子和标志物,从而使干细胞领域能够提高iPSC造血的效率和功效。我们采用了一个四阶段分化方案,包括:胚状体(EB)形成(第1阶段);用造血细胞因子培养EB(第2阶段);HSPC扩增(第3阶段);以及中性粒细胞成熟(第4阶段)。在第3阶段培养物中观察到CD34(+) CD45(-)假定造血内皮细胞,它们表达VEGFR-2/Flk-1/KDR和VE-钙黏蛋白内皮标志物、GATA-2、AML1/RUNX1和SCL/TAL1转录因子,以及内皮/HSPC相关的微小RNA miR-24、miR-125a-3p、miR-126/126*和miR-155。进一步培养后,CD34(+) CD45(-)细胞产生了能形成造血集落形成单位(CFU)的CD34(+) CD45(+) HSPC。第3阶段中期的CD34(+) CD45(+) HSPC表现出GATA-2、AML1/RUNX1、SCL/TAL1、C/EBPα和PU.1转录因子表达增加,但HSPC相关微小RNA的表达降低,并且不能在免疫缺陷小鼠中植入。第3阶段中期的CD34(-) CD45(+)细胞维持PU.1表达,并表现出血液生成相关的miR-142-3p/5p表达增加以及miR-223表达有增加趋势,表明髓系定向分化。到第4阶段后期,观察到CD15、CD16b和C/EBPɛ表达增加,25%-65%的细胞表现出成熟中性粒细胞的形态和功能。这些研究表明,从人iPSC进行的造血和中性粒细胞分化概括了胚胎造血和骨髓中中性粒细胞生成的许多特征,但揭示了可能有助于增强iPSC造血的意外分子特征。《干细胞》2016年;34卷:1513 - 1526页